Symetrify

Wearable Training Device for Treatment of Chronic Low Back Pain

Health Tech & Life Sciences
Active
Seed Modi'in-Maccabim-Re'ut, Israel Founded 2022
Last updated 2026-06-18
Total raised
$1.0M
Last: 2022-02
Stage
Seed
Founded
2022
Headcount
2
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences

About

Symetrify is the developer of the L-PACT, a neuromechanical wearable training device for assessing, treating, and preventing spinal kinetic dysfunctions related to chronic low back pain (CLBP). The L-PACT targets the functional-mechanical root cause of CLBP by balancing the functional motion of the lumbo-pelvic load distribution axis base, providing an automatic training solution to stop the degenerative process that leads to CLBP over time.

The L-PACT trains the body’s self-neurological regulation to balance postural kinetic function through a safe, short, noninvasive automated process designed to reduce uneven pressure loads on intervertebral discs, joints, and supporting structures. Based on data-driven AI algorithms, the technology provides predictive markers for developing low back motion imbalances, offering personalized, long-lasting therapeutic effects for patients and increased treatment capacity and efficiency for clinicians and clinics.

Funding history · 1 round · $1.0M total

Q&A

What is Symetrify's primary product?
Symetrify develops the L-PACT, a neuromechanical wearable training device designed for assessing, treating, and preventing spinal kinetic dysfunctions associated with chronic low back pain (CLBP).
When was Symetrify founded?
Symetrify was founded in February 2022.
How much funding has Symetrify raised to date?
Symetrify has raised a total of $1,000,000.
Which investors participated in Symetrify's funding round?
In February 2022, Symetrify received funding from eHealth Ventures and Israel Innovation Authority.
What is Symetrify's primary sector?
Symetrify operates in the Health Tech & Life Sciences sector.
What technologies does Symetrify utilize in its product?
Symetrify's technology is based on Artificial Intelligence, Platforms & Interfaces, and Software.
What is the target customer segment for Symetrify's product?
Symetrify targets customers in Healthcare & Life Sciences, specifically Healthcare Providers.

Team · 2

Founder · Co-founder
LinkedIn ↗
Founder · CMO, R&D
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligencePlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

wearablephysiotherapyalgorithmsautomationsoftware-applicationsdigital-healthcaretreatmentsdigital-therapeuticspersonalizationartificial-intelligencemedical-devicesreal-timenon-invasivechronic-painwearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesymetrify.com
LinkedInlinkedin.com/company/88473049

Identifiers & details

Former namesSkelekinetics
Founded2022-2
Employees (exact)2

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainsymetrify.com

Certificate / subdomain footprint

Subdomains8